Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Evaluating Gvhd Outcomes Using Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil As Gvhd Prophylaxis Compared with Methotrexate/Tacrolimus in Matched-Related and Matched-Unrelated Hematopoietic Stem Cell Transplant in Relation to the Haplo-Identical Setting: A Single Center Experience

Mindy Hsiao, MD, Preet M. Chaudhary, MD PhD, George Yaghmour, MD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-141659

Published: 2020

Journal Articles

Outcomes of Therapy with Venetoclax Combined with Hypomethylating Agents in Favorable-Risk Acute Myeloid Leukemia (AML)

Shukaib Arslan, MD, Jianying Zhang, Prajwal Dhakal, MBBS, Jenna A. Moran, NP, Nuthana Naidoo, Jennifer Lombardi Story, Vinod A. Pullarkat, MD, Anthony S. Stein, MD, Guido Marcucci, MD, George Yaghmour, MD, Vijaya R. Bhatt, MD, Amir T. Fathi, Ibrahim Aldoss, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-142780

Published: 2020

Journal Articles

Real-World Experience Using Letermovir for CMV Prophylaxis in High-Risk Allogeneic Hematopoietic Stem Cell Patients in the Setting of Using T-Cell Depletion As Gvhd Prophylaxis and the Impact on CMV Reactivation, 1-Year Overall Survival, and 1-Year Gvhd-Free-Relapse-Free Survival

Sami Dwabe, MD, Mindy Hsiao, MD, George Yaghmour, MD

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-143309

Published: 2020

Journal Articles

Minimal Residual Disease Detection in Adults with Acute Lymphoblastic Leukemia By Next Generation Sequencing: Impact on Clinical Outcomes

Lissette Cervantes, MD, Lan Wang, MD, George Yaghmour, MD, Andrei Varnavski, PhD, Imran Siddiqi, MDPhD

Blood (2020) 136 (Supplement 1): 9.

https://doi.org/10.1182/blood-2020-143416

Published: 2020

Journal Articles

Investigating the Relationship between CD34 + and CD3 + Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation: A Single Center Experience

Mindy Hsiao, MD, Anastasia Martynova, MD, George Yaghmour, MD, Chris Foss, MD

Blood (2019) 134 (Supplement_1): 2051.

https://doi.org/10.1182/blood-2019-129647

Published: 2019

Journal Articles

Combination Chemotherapy Plus Dasatinib Leads to Comparable Rates of Overall Survival and Relapse-Free Survival As Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia

Jeremy Chang, MD, Golnaz Vahdani, MD, George Yaghmour, MD, Kum-Ja Lee, PharmD, Ashley Weissman, PharmD, Mojtaba Akhtari, MD

Blood (2018) 132 (Supplement 1): 4629.

https://doi.org/10.1182/blood-2018-99-110229

Published: 2018

Journal Articles

Increased Risk of 100-Day and 1-Year Infection-Related Mortality in Haploidentical Stem Cell Transplantation Patients

Jeremy Chang, MD, Golnaz Vahdani, MD, George Yaghmour, MD, Ashley Weissman, PharmD, Kum-Ja Lee, PharmD, Mojtaba Akhtari, MD

Blood (2018) 132 (Supplement 1): 4630.

https://doi.org/10.1182/blood-2018-99-111404

Published: 2018

Journal Articles

Pre-Transplant Low Dose Cyclophosphamide Enhances Engraftment and Immune Reconstitution in Haploidentical Hematopoietic Stem Cell Transplant (HCT) Recipients Receiving Total Body Radiation (TBI) Free Reduced Intensity Conditioning with Post- Transplant Cyclophosphamide (PTCY)

Yasser Khaled, MD, George Yaghmour, MD, Christy R Parks, FNP, Deborah Lamontagne, MLS(ASCP)CM, Joshua Boss, RN, Diwura Owolabi, PharmD, BCOP, Sallyanne C. Fossey, PhD, Lisa Murphy, MT(ASCP), Robert Bradley, MD

Blood (2016) 128 (22): 3431.

https://doi.org/10.1182/blood.V128.22.3431.3431

Published: 2016

Journal Articles

Age and Population-Based Early Mortality Rate (EMR) in Acute Myeloid Leukemia (AML) Versus the EMR Reported By SWOG

George Yaghmour, MD, Andrew Hahn, Michael G Martin, MD

Blood (2014) 124 (21): 3665.

https://doi.org/10.1182/blood.V124.21.3665.3665

Published: 2014

Journal Articles

The Prognostic Implications of Nucleated Red Blood Cells in Myelodysplastic Syndrome

Javier Munoz, MD, Mohamad A. Younes, MD, Marwa Hammoud, Ammar Khanshour, MD, Rosa Michel Ortega, MD, Mohammad Alhyari, MD, George Yaghmour, MD, Philip Kuriakose, MD

Blood (2011) 118 (21): 5058.

https://doi.org/10.1182/blood.V118.21.5058.5058

Published: 2011

Journal Articles

Risk of Venous Thromboembolism in Patients with Myelodysplatic Syndrome

Mohamad A. Younes, MD, Javier Munoz, M.D., Ammar Khanshour, MD, Jessica Schering, MD, George Yaghmour, MD, Mohammad Alhyari, MD, Rosa Michel Ortega, MD, Philip Kuriakose, MD

Blood (2011) 118 (21): 5245.

https://doi.org/10.1182/blood.V118.21.5245.5245

Published: 2011

NARROW

Outcomes of Therapy with Venetoclax Combined with Hypomethylating Agents in Favorable-Risk Acute Myeloid Leukemia (AML)

Real-World Experience Using Letermovir for CMV Prophylaxis in High-Risk Allogeneic Hematopoietic Stem Cell Patients in the Setting of Using T-Cell Depletion As Gvhd Prophylaxis and the Impact on CMV Reactivation, 1-Year Overall Survival, and 1-Year Gvhd-Free-Relapse-Free Survival

Minimal Residual Disease Detection in Adults with Acute Lymphoblastic Leukemia By Next Generation Sequencing: Impact on Clinical Outcomes

Investigating the Relationship between CD34 + and CD3 + Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation: A Single Center Experience

Combination Chemotherapy Plus Dasatinib Leads to Comparable Rates of Overall Survival and Relapse-Free Survival As Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia

Increased Risk of 100-Day and 1-Year Infection-Related Mortality in Haploidentical Stem Cell Transplantation Patients

Pre-Transplant Low Dose Cyclophosphamide Enhances Engraftment and Immune Reconstitution in Haploidentical Hematopoietic Stem Cell Transplant (HCT) Recipients Receiving Total Body Radiation (TBI) Free Reduced Intensity Conditioning with Post- Transplant Cyclophosphamide (PTCY)

Age and Population-Based Early Mortality Rate (EMR) in Acute Myeloid Leukemia (AML) Versus the EMR Reported By SWOG

The Prognostic Implications of Nucleated Red Blood Cells in Myelodysplastic Syndrome

Risk of Venous Thromboembolism in Patients with Myelodysplatic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only